J-GLOBAL ID：202001002692990543
Update date: Mar. 09, 2026
Takizawa Hotake
タキザワ ホタケ | Takizawa Hotake
Research theme for competitive and other funds (1)：
2020 - 2022 ジストロフィン異常症保因者の骨格筋におけるジストロフィンの解析
Papers (27)：
Rui Shimazaki, Satoru Noguchi, Wakako Yoshioka, Hotake Takizawa, Yuji Takahashi, Shinichiro Hayashi, Ichizo Nishino. Muscle imaging of patients with RYR1-related myopathies and its significance to clinical features. Neuromuscular disorders : NMD. 2025. 56-57. 106275-106275
Jun Shinmi, Hotake Takizawa, Yoshihiko Saito, Ayano Matsui, Yasushi Oya, Ryoichi Sakuta, Ichizo Nishino, Yuji Takahashi. COL12A1-related Myopathic Ehlers-Danlos Syndrome with Chiari I Malformation: A Clinical Report. European Journal of Medical Genetics. 2025. 105057-105057
Chaitra Sathyaprakash, Eri Takeuchi, Hotake Takizawa, Yuki Ashida, Tsukasa Tominari, Yusuke Echigoya, Toshifumi Yokota, Yoshitsugu Aoki. In Vivo Evaluation of Single- and Multi-Exon-Skipping in mdx52 Mice. Methods in Molecular Biology. 2025. 243-261
Eri Takeuchi, Chaitra Sathyaprakash, Hotake Takizawa, Norio Motohashi, Yusuke Echigoya, Toshifumi Yokota, Yoshitsugu Aoki. Exon-Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy. Methods in molecular biology (Clifton, N.J.). 2025. 2964. 487-499
Modelling Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-deazaneplanocin A hydrochloride
(第40回国立精神・神経医療研究センター神経研究所 研究所発表会)
Modelling of Duchenne muscular dystrophy in MYOD1-converted urine-derived cells treated with 3-Deazaneplanocin A Hydrochloride
(「ジストロフィン欠損モデル動物を基盤とした筋ジストロフィーの新しい治療法開発」班)
A new non-invasive and efficient evaluation of exon-skipping on patients’ urine-derived cells
Establishment of a non-invasive and efficient in vitro assay system for exon skipping therapy
(日本筋学会第4回学術集会)
Establishment of a non-invasive and efficient in vitro assay system for exon skipping therapy
(11th Japanese-French Workshop)
